Huntington's Disease
Huntington's disease is a hereditary condition that causes the progressive breakdown of nerve cells in the brain, leading to movement, cognitive, and psychiatric disorders.
Huntington's Disease: Innovative Biomarker Study
We are exploring new imaging and cognitive markers to better understand how Huntington's disease progresses. This study aims to identify effective ways to track the disease from early stages.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 65 years old?
- Are you pregnant or breastfeeding?
- Do you have Huntington's disease or a family history of it?
- Do you have any major neurological or psychiatric disorders unrelated to Huntington's disease?
- Are you currently participating in another clinical trial?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
MNI-659
3-Dione
Isoindole
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Assistance Publique Hopitaux De Paris
Service de Neuroradiologie
Créteil, France
Assistance Publique Hopitaux De Paris
Centre d’Investigation Clinique
Créteil, France
Assistance Publique Hopitaux De Paris
Service de Neurologie
Créteil, France
Sponsor: Assistance Publique Hopitaux De Paris
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.